J Fluoresc
2H, ArH), 6.94 (dd, J=7.7, 3.9 Hz, 2H, ArH), 4.71 (s, 2H,
CH2), 2.33 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ/
ppm 164.23, 159.91, 154.15, 152.69, 151.98, 147.57, 142.75,
134.45, 132.62, 129.05, 124.88, 118.85, 116.54, 116.42,
116.01, 68.05, 14.88; IR (KBr) ν/cm−1: 3241, 3053, 1711,
1653, 1613, 1247, 736; MS (EI) m/z (%): 356 (M+2, 1), 355
(M+1, 4), 354 (M, 23), 229 (100), 187 (32), 115 (35), 89 (17),
75 (13), 63 (12); Anal. Calcd. for C19H15FN2O4: C, 64.40; H,
4.27, N, 7.91; O, 18.06. Found: C, 67.45; H, 4.32, N, 7.87.
(E)-2-(4-chlorophenoxy)-N’-(1-(2-oxo-2H-chromen-3-
yl)ethylidene)acetohydrazide (L3). Yellow crystals. Yield:
(E)-2-(4-methoxyphenoxy)-N’-(1-(2-oxo-2H-chromen-3-
yl)ethylidene)acetohydrazide (L6). Pale yellow needle crys-
tals. Yield: 76 %. m.p. 151−153 °C; H NMR (400 MHz,
1
CDCl3) δ/ppm: 9.58 (s, 1H, NH), 8.22 (s, 1H, CH), 7.57−
7.59 (d, J=7.7 Hz, 2H, ArH), 7.39−7.31 (m, 2H, ArH), 6.86−
6.93 (m, 4H, ArH), 4.69 (s, 2H, CH2), 3.80 (s, 3H, OCH3),
2.32 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ/ppm:
164.72, 159.90, 155.14, 151.79, 151.07, 150.94, 142.73,
132.58, 129.04, 124.87, 118.86, 116.53, 116.03, 115.81,
115.05, 68.18, 55.72, 14.89; IR (KBr) ν/cm−1: 3246, 3055,
1710, 1649, 1613, 1245, 738; MS (EI) m/z (%): 368 (M+2,
1), 367 (M+1, 7), 366 (M, 28). 200 (100), 171 (13), 115 (37),
89 (15), 63 (16); Anal. Calcd. for C20H18N2O5: C, 65.57; H,
4.95 N, 7.65; O, 21.84. Found: C, 65.56; H, 4.91; N, 7.67.
(E)-N’-(1-(2-oxo-2H-chromen-3-yl)ethylidene)-2-(p-
tolyloxy)acetohydrazide (L7). Pale yellow solid. Yield: 74 %.
m.p. 147−150 °C; 1H NMR (400 MHz, CDCl3) δ/ppm: 9.57 (s,
1H, NH), 8.22 (s, 1H, CH), 7.57−7.59 (m, J=7.7 Hz, 2H, ArH),
7.31−7.38 (m, 2H, ArH), 7.15 (d, J=8.0 Hz, 2H, ArH), 6.88 (d,
J=7.9 Hz, 2H, ArH), 4.71 (s, 2H, CH2), 2.32 (d, J=4.9 Hz, 6H,
CH3); 13C NMR (100 MHz, CDCl3) δ/ppm: 164.65, 159.89,
154.76, 154.13, 151.72, 142.65, 132.54, 130.44, 129.03,
128.76, 126.00, 124.85, 118.86, 116.51, 114.53, 67.52, 20.54,
14.85; IR (KBr) ν/cm−1: 3248, 3058, 1711, 1650, 1612, 1245,
746; MS (EI) m/z (%): 352 (M+2, 2), 351 (M+1, 13), 350 (M,
45), 229 (85), 215 (M, 43), 187 (43), 115 (47), 91 (100), 65 (26);
Anal. Calcd. for C20H18N2O4: C, 68.56; H, 5.18 N, 8.00; O,
18.27. Found: C, 68.55; H, 5.20; N, 7.96.
1
70 %. m.p. 157−159 °C; H NMR (400 MHz, CDCl3)
δ/ppm: 9.50 (s, 1H, NH), 8.22 (s, 1H, CH), 7.57−7.59 (m,
J=8.0 Hz, 2H), 7.36−7.39 (d, J=11.2 Hz, 2H, ArH), 7.32−
7.34 (m, J=9.4 Hz, 2H, ArH), 6.92 (d, J=7.7 Hz, 2H,ArH),
4.71 (s, 2H, CH2), 2.33 (s, 3H, CH3); 13C NMR (100 MHz,
CDCl3) δ/ppm: 163.93, 159.92, 155.38, 154.17, 147.54,
142.72, 132.62, 129.98, 129.42, 129.04, 124.88, 118.84,
116.56, 116.17, 116.02, 67.62, 14.89; IR (KBr) ν/cm−1:
3244, 3065, 1710, 1650, 1613, 1249, 736; MS (EI) m/z (%):
373.1 (M+3, 2), 372.1 (M+2, 7), 370.1 (M, 25), 229.1 (100),
187.1 (27), 141.1 (14) 115.1 (45), 89.1 (21), 75.1 (17), 63.1
(15); Anal. Calcd. for C19H15ClN2O4: C, 61.55; H, 4.08 N,
7.56; O, 17.26. Found: C, 61.63; H, 4.06; N,7.58.
(E)-2-(4-bromophenoxy)-N’-(1-(2-oxo-2H-chromen-3-
yl)ethylidene)acetohydrazide (L4). Pale yellow crystals. Yield:
68 %. m.p. 165−168 °C; 1H NMR (400 MHz, CDCl3) δ/ppm:
9.49 (s, 1H, NH), 8.22 (s, 1H, CH), 7.58−7.60 (m, J=8.0 Hz,
2H, ArH), 7.46−7.48 (d, J=8.2 Hz, 2H), 7.36−7.38 (m, J=
4.5 Hz, 2H, ArH), 6.88 (d, J=8.4 Hz, 2H), 4.71 (s, 2H, CH2),
2.33 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3) δ/ppm: 163.89,
159.87, 155.90, 154.16, 152.03, 142.72, 132.92, 132.62, 132.35,
129.04, 124.88, 118.83, 116.68, 116.49, 115.13, 67.53, 14.90. IR
(KBr) ν/cm−1: 3243, 3055, 1713, 1651, 1613, 1246, 744; MS
(EI) m/z (%): 418 (M+3, 1), 417 (M+2, 4), 415 (M, 13), 414
(M-1, 15), 229 (100), 215 (23), 187 (33), 115 (38), 89 (17), 76
(12), 63 (13); Anal. Calcd. for C19H15BrN2O4: C, 54.96; H, 3.64,
N, 6.75; O, 15.41. Found: C, 54.97; H, 3.66; N, 6.73.
(E)-2-(4-nitrophenoxy)-N’-(1-(2-oxo-2H-chromen-3-
yl)ethylidene)acetohydrazide (L5). Yellow needle crystals.
Yield: 72 %. m.p. 160−163 °C; 1H NMR (400 MHz, DMSO)
δ/ppm 11.13 (s, 1H, NH), 8.36 (s, 1H, CH), 8.21 (d, J=8.5 Hz,
2H, ArH), 7.81 (d, J=7.5 Hz, 1H, ArH), 7.65 (t, J=7.7 Hz,
1H, ArH), 7.41−7.44 (dd, J=15.1, 7.7 Hz, 2H, ArH), 7.15 (d,
J=8.3 Hz, 2H, ArH), 5.38 (s, 2H, CH2), 2.23 (s, 3H, CH3);
13C NMR (101 MHz, DMSO) δ/ppm: 169.65, 164.11, 159.57,
153.87, 147.42, 142.23, 141.40, 132.95, 129.60, 126.84,
126.19, 125.28, 119.32, 116.51, 115.66, 66.35, 16.04. IR
(KBr) ν/cm−1: 3245, 3067, 1708, 1651, 1611, 1247, 745;
MS (EI) m/z (%): 382 (M+1, 4), 381 (M, 16), 229 (100),
200 (62), 186 (22), 115 (45), 89 (20); Anal. Calcd. for
C19H15N3O6: C, 59.84; H, 3.96 N, 11.02; O, 25.17. Found:
C, 59.87; H, 3.99; N, 10.98.
Synthesis of the Title Europium Complexes
Synthetic methods of the title europium complexes were sim-
ilar, so the synthetic process of the complex of compound L1
was expressed as example. The compound L1 (0.50 mmol,
0.18 g) was dissolved in 30 mL chloroform in a 100 mL
three-neck flask, then 5 mL europium nitrate ethanol solution
(0.1 mol·L−1) was added. The pH value of the mixture was
adjusted to 6−7 by an aqueous solution of NaOH (1 mol·L−1).
The reaction mixture was heated to reflux for 2 h at 60 °C. The
precipitated was collected by filtration, and washed several
times with chloroform, and then dried in drying oven for 8 h
to give complex with ligand L1. The general synthesis proce-
dures of other complexes with ligands L2−7 are similar to that
of complex with ligand L1.
Results and Discussion
Composition and Physical Properties of the Complexes
Analytical data for the newly synthesized title complexes are
given in Table 1. Compounds L1−7 were easily dissolved in
chloroform, DMSO, DMF, acetone and dichloromethane, but